Key Insights

Highlights

Success Rate

85% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 52/100

Termination Rate

11.1%

3 terminated out of 27 trials

Success Rate

85.0%

-1.5% vs benchmark

Late-Stage Pipeline

26%

7 trials in Phase 3/4

Results Transparency

24%

4 of 17 completed with results

Key Signals

4 with results85% success

Data Visualizations

Phase Distribution

18Total
Not Applicable (9)
P 1 (1)
P 2 (1)
P 3 (5)
P 4 (2)

Trial Status

Completed17
Unknown4
Terminated3
Enrolling By Invitation1
Recruiting1
Active Not Recruiting1

Trial Success Rate

85.0%

Benchmark: 86.5%

Based on 17 completed trials

Clinical Trials (27)

Showing 20 of 20 trials
NCT07081997Phase 3Recruiting

A Phase 3 Randomized Clinical Trial to Investigate the Safety and Efficacy of Palopegteriparatide at Doses Greater Than 30 μg/Day in Adult Participants With Hypoparathyroidism

NCT04701203Phase 3Completed

A Trial Investigating the Safety, Tolerability and Efficacy of TransCon PTH Administered Daily in Adults With Hypoparathyroidism

NCT05387070Phase 3Completed

PaTHway CHINA TRIAL: A Trial to Investigating the Safety, Tolerability and Efficacy of TransCon PTH in Adults With Hypoparathyroidism

NCT05152927Not ApplicableCompletedPrimary

Near Infrared Autofluorescence (NIRAF) Detection for Identifying Parathyroid Glands During Parathyroidectomy

NCT05778071Phase 3Active Not Recruiting

Evaluation of the Safety and Efficacy of Eneboparatide (AZP-3601) in Patients With Chronic Hypoparathyroidism

NCT07173621Not ApplicableEnrolling By Invitation

Comparing the Impact of AMNIOEFFECT Application vs Standard of Care on Post-Operative Healing in Patients Who Have Undergone Thyroid and Parathyroid Surgery Via the Transcutaneous Approach

NCT05022667Not ApplicableCompleted

Assessing Benefits of Near Infrared Autofluorescence (NIRAF) Detection for Identifying Parathyroid Glands During Total Thyroidectomy

NCT04009291Phase 2Completed

A Trial Investigating the Safety, Tolerability and Efficacy of TransCon PTH in Adults With Hypoparathyroidism

NCT06274970Not ApplicableCompleted

PaThERAS: ERAS Protocols in Thyroid & Parathyroid Surgery

NCT05294393Phase 4Completed

Ropivacaine Plus Magnesium Sulphate Infiltration

NCT04589884TerminatedPrimary

Intraoperative EXamination Using MAChine-learning-based HYperspectral for diagNosis & Autonomous Anatomy Assessment

NCT04745793Terminated

Precise Recognition With Enhanced Vision of Endocrine Neck Targets

NCT05688007Completed

The Association Between Parathyroid Hormone and Preterm Labor

NCT04344886Not ApplicableCompleted

Optimization and Individualization of Diagnostic Scintigraphy Protocol and Minimally Invasive Radio-guided Parathyroid Surgery

NCT05432050Unknown

Bispectral Index and Patient State Index During General Anesthesia With Remimazolam

NCT05243979Unknown

The Relation Between Thyroid , Parathyroid Hormones and eGFR in CKD Patients in Assiut

NCT04704349Not ApplicableCompleted

Latest Imaging SPECT System Evaluation Phase 1

NCT04569513Unknown

The Analysis of Thyroidectomy and Parathyroidectomy

NCT03469310Phase 4Completed

Minimizing Narcotic Analgesics After Endocrine Surgery

NCT03747029Completed

Serum Calcium to Phosphorous (Ca/P) Ratio in the Diagnosis of Ca-P Metabolism Disorders: a Multicentre Study

Scroll to load more

Research Network

Activity Timeline